Chr. Hansen Holding A/S (OTCMKTS:CHYHY) Receives Consensus Rating of “Hold” from Brokerages

Chr. Hansen Holding A/S (OTCMKTS:CHYHY – Get Rating) has earned a consensus rating of “Hold” from the nine analysts that are covering the company, Marketbeat reports. Six research analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $492.50.

Several brokerages have recently weighed in on CHYHY. Credit Suisse Group raised their target price on Chr. Hansen Holding A/S from 455.00 to 475.00 and gave the stock a “neutral” rating in a research report on Friday, January 6th. Jefferies Financial Group raised Chr. Hansen Holding A/S from an “underperform” rating to a “hold” rating in a research report on Monday, December 12th. BNP Paribas raised Chr. Hansen Holding A/S to a “neutral” rating in a research report on Tuesday, December 13th. Exane BNP Paribas raised Chr. Hansen Holding A/S from an “underperform” rating to a “neutral” rating in a research report on Tuesday, December 13th. Finally, DNB Markets raised Chr. Hansen Holding A/S from a “hold” rating to a “buy” rating in a research report on Wednesday, December 28th.

Chr. Hansen Holding A/S Price Performance

Shares of OTCMKTS CHYHY opened at $18.09 on Friday. Chr. Hansen Holding A/S has a fifty-two week low of $11.78 and a fifty-two week high of $21.40. The stock’s 50-day simple moving average is $17.00 and its 200-day simple moving average is $15.45.

Chr. Hansen Holding A/S Cuts Dividend

The company also recently declared a dividend, which was paid on Monday, December 5th. Investors of record on Thursday, November 24th were paid a dividend of $0.1478 per share. The ex-dividend date of this dividend was Wednesday, November 23rd. This represents a yield of 0.97%.

Chr. Hansen Holding A/S Company Profile

(Get Rating)

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments.